Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001380048 | SCV001577980 | pathogenic | Renal carnitine transport defect | 2023-06-23 | criteria provided, single submitter | clinical testing | Experimental studies have shown that this missense change affects SLC22A5 function (PMID: 28841266). This sequence change replaces leucine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 507 of the SLC22A5 protein (p.Leu507Ser). This variant is present in population databases (no rsID available, gnomAD 0.007%). This missense change has been observed in individual(s) with primary carnitine deficiency (PMID: 20574985). ClinVar contains an entry for this variant (Variation ID: 1068475). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC22A5 protein function. For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV001380048 | SCV005056776 | likely pathogenic | Renal carnitine transport defect | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV001380048 | SCV005669237 | likely pathogenic | Renal carnitine transport defect | 2024-03-05 | criteria provided, single submitter | clinical testing | |
Giacomini Lab, |
RCV001380048 | SCV002576724 | uncertain significance | Renal carnitine transport defect | 2022-10-03 | flagged submission | research |